| For: | Jin HL, Zhu H, Ling TS, Zhang HJ, Shi RH. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis. World J Gastroenterol 2009; 15(47): 5983-5991 [PMID: 20014464 DOI: 10.3748/wjg.15.5983] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i47/5983.htm |
| Number | Citing Articles |
| 1 |
Kosuke Narumiya, Ralf Metzger, Elfriede Bollschweiler, Hakan Alakus, Jan Brabender, Uta Drebber, Arnulf H Hölscher, Ute Warnecke-Eberz.
Impact of
ABCB1
C3435T Polymorphism on Lymph node Regression in Multimodality Treatment of Locally Advanced Esophageal Cancer
. Pharmacogenomics 2011; 12(2) doi: 10.2217/pgs.10.174
|
| 2 |
M Kranzfelder, T Schuster, H Geinitz, H Friess, P Büchler. Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer. British Journal of Surgery 2011; 98(6) doi: 10.1002/bjs.7455
|
| 3 |
Daniel Vallböhmer, Jan Brabender, Peter Grimminger, Wolfgang Schröder, Arnulf H Hölscher. Predicting response to neoadjuvant therapy in esophageal cancer. Expert Review of Anticancer Therapy 2011; 11(9) doi: 10.1586/era.11.126
|
| 4 |
Daniel Lin, Lawrence Leichman. The Current Status of Neoadjuvant Therapy for Esophageal Cancer. Seminars in Thoracic and Cardiovascular Surgery 2014; 26(2) doi: 10.1053/j.semtcvs.2014.07.002
|
| 5 |
K. Maruyama, S. Motoyama, A. Anbai, S. Usami, Y. Sato, K. Shibuya, K. Yoshino, T. Nakatsu, Y. Minamiya, J.-I. Ogawa. Therapeutic strategy for the treatment of postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy of radiotherapy. Diseases of the Esophagus 2011; 24(3) doi: 10.1111/j.1442-2050.2010.01119.x
|
| 6 |
William S. Twaddell, Peter C. Wu, Roy J.J. Verhage, Marcus Feith, David H. Ilson, Christoph P. Schuhmacher, James D. Luketich, Björn Brücher, Daniel Vallböhmer, Wayne L. Hofstetter, Mark Jonathan Krasna, Daniela Kandioler, Paul M. Schneider, Bas P.L. Wijnhoven, Stephen J. Sontag. Barrett's esophagus: treatments of adenocarcinomas II. Annals of the New York Academy of Sciences 2011; 1232(1) doi: 10.1111/j.1749-6632.2011.06056.x
|
| 7 |
Luis F. Tapias, Christopher R. Morse. Minimally Invasive Ivor Lewis Esophagectomy after Induction Therapy Yields Similar Early Outcomes to Surgery Alone. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery 2011; 6(5) doi: 10.1097/imi.0b013e3182364e5d
|
| 8 |
Kazuki Ishikawa, Kiyoshi Nakamatsu, Osamu Shiraishi, Takushi Yasuda, Yasumasa Nishimura. Clinical results of definitive-dose (50 Gy/25 fractions) preoperative chemoradiotherapy for unresectable esophageal cancer. International Journal of Clinical Oncology 2015; 20(3) doi: 10.1007/s10147-014-0736-9
|
| 9 |
Bryan H. Burmeister, Janine M. Thomas, Elizabeth A. Burmeister, Euan T. Walpole, Jennifer A. Harvey, Damien B. Thomson, Andrew P. Barbour, David C. Gotley, B. Mark Smithers. Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial. European Journal of Cancer 2011; 47(3) doi: 10.1016/j.ejca.2010.09.009
|
| 10 |
Marjolein Y.V. Homs, Martijn G.H. van Oijen, Bas P.L. Wijnhoven, Richard van Hillegersberg, Maureen de Boer-Dennert, Peter D. Siersema. Changes in diagnostic and treatment strategies of oesophageal cancer in the period from 2001 to 2009. European Journal of Gastroenterology & Hepatology 2012; 24(2) doi: 10.1097/MEG.0b013e32834e7f29
|
| 11 |
Meike M.C. Hirdes, Peter Siersema. Endoprosthetics for malignant esophageal disease. Techniques in Gastrointestinal Endoscopy 2014; 16(2) doi: 10.1016/j.tgie.2014.07.004
|
| 12 |
Mark D. Iannettoni. Invited Commentary. The Annals of Thoracic Surgery 2011; 92(6) doi: 10.1016/j.athoracsur.2011.09.041
|
| 13 |
Geertjan van Tienhoven, Dirk J. Gouma, Dick J. Richel. Neoadjuvant chemoradiotherapy has a potential role in pancreatic carcinoma. Therapeutic Advances in Medical Oncology 2011; 3(1) doi: 10.1177/1758834010383150
|
| 14 |
K Kumagai, I Rouvelas, J A Tsai, D Mariosa, F Klevebro, M Lindblad, W Ye, L Lundell, M Nilsson. Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers. British Journal of Surgery 2014; 101(4) doi: 10.1002/bjs.9418
|
| 15 |
J. Straatman, P. J. M. Joosten, C. B. Terwee, M. A. Cuesta, E. P. Jansma, D. L. van der Peet. Systematic review of patient-reported outcome measures in the surgical treatment of patients with esophageal cancer. Diseases of the Esophagus 2016; 29(7) doi: 10.1111/dote.12405
|
| 16 |
Amin Doosti-Irani, Mohammad Ali Mansournia, Abbas Rahimi-Foroushani, Peiman Haddad, Kourosh Holakouie-Naieni. Local recurrence of esophageal squamous cell carcinoma after treatment: Comparison of frequentist and Bayesian network meta-analysis. Clinical Epidemiology and Global Health 2019; 7(2) doi: 10.1016/j.cegh.2018.02.009
|
| 17 |
Li-Li Zhu, Ling Yuan, Hui Wang, Lin Ye, Gui-Ying Yao, Cui Liu, Niu-Niu Sun, Xiao-Jing Li, Shi-Cong Zhai, Ling-Juan Niu, Jun-Bo Zhang, Hong-Long Ji, Xiu-Min Li, Kevin Camphausen. A Meta-Analysis of Concurrent Chemoradiotherapy for Advanced Esophageal Cancer. PLOS ONE 2015; 10(6) doi: 10.1371/journal.pone.0128616
|
| 18 |
A. van Nunen, M.J.C. van der Sangen, M. van Boxtel, P.M.A. van Haaren. Cone-Beam CT-based position verification for oesophageal cancer: Evaluation of registration methods and anatomical changes during radiotherapy. Technical Innovations & Patient Support in Radiation Oncology 2017; doi: 10.1016/j.tipsro.2017.07.002
|
| 19 |
Bin Zheng, Wei Zheng, Yong Zhu, Xiao-yan Lin, Ben-hua Xu, Chun Chen. Role of adjuvant chemoradiotherapy in treatment of resectable esophageal carcinoma: a meta-analysis. Chinese Medical Journal 2013; 126(6) doi: 10.3760/cma.j.issn.0366-6999.20121798
|
| 20 |
Laurent Bedenne, Julie Vincent, Jean-Louis Jouve. Is surgery always necessary in esophageal cancer?. Esophagus 2011; 8(1) doi: 10.1007/s10388-011-0258-8
|
| 21 |
Amy M. Buckley, Margaret R. Dunne, Niamh Lynam-Lennon, Susan A. Kennedy, Aoife Cannon, Alison L. Reynolds, Stephen G. Maher, John V. Reynolds, Breandán N. Kennedy, Jacintha O'Sullivan. Pyrazinib (P3), [(E)-2-(2-Pyrazin-2-yl-vinyl)-phenol], a small molecule pyrazine compound enhances radiosensitivity in oesophageal adenocarcinoma. Cancer Letters 2019; 447 doi: 10.1016/j.canlet.2019.01.009
|
| 22 |
A. H. Hölscher, E. Bollschweiler. Early Gastrointestinal Cancers. Recent Results in Cancer Research 2012; 196 doi: 10.1007/978-3-642-31629-6_11
|
| 23 |
K. Ott, L. Sisic, M. Büchler. Plattenepithelkarzinom des Ösophagus. Der Chirurg 2011; 82(11) doi: 10.1007/s00104-011-2128-2
|
| 24 |
Masanobu Nakajima, Hiroyuki Kato. Treatment options for esophageal squamous cell carcinoma. Expert Opinion on Pharmacotherapy 2013; 14(10) doi: 10.1517/14656566.2013.801454
|
| 25 |
Jian-Hua Fu, Jun-Ying Chen, Qing-Yuan Huang, Kong-Jia Luo, Qian-Wen Liu, Hong Yang, Jing Wen, Xiao-Xiao Ding-Lin, Yi Hu, Wei Zhao, Yu-Zhen Zheng. Aggressive surgical resection does not improve survival in operable esophageal squamous cell carcinoma with N2-3 status. World Journal of Gastroenterology 2015; 21(28): 8644-8652 doi: 10.3748/wjg.v21.i28.8644
|
| 26 |
Haiming Feng, Ye Zhao, Tao Jing, Jianxing Ma, Yinglu Zhao, Jianhua Zhang, Cheng Wang, Bin Li. Traditional and cumulative meta‑analysis: Chemoradiotherapy followed by surgery versus surgery alone for resectable esophageal carcinoma. Molecular and Clinical Oncology 2017; doi: 10.3892/mco.2017.1534
|
| 27 |
Yasunori Akutsu, Shigeo Yasuda, Matsuo Nagata, Yosuke Izumi, Shinichi Okazumi, Hideaki Shimada, Yukio Nakatani, Hirohiko Tsujii, Tadashi Kamada, Shigeru Yamada, Hisahiro Matsubara. A phase I/II clinical trial of preoperative short‐course carbon‐ion radiotherapy for patients with squamous cell carcinoma of the esophagus. Journal of Surgical Oncology 2012; 105(8) doi: 10.1002/jso.22127
|
| 28 |
Amy M. Buckley, Niamh Lynam-Lennon, Susan A. Kennedy, Margaret R. Dunne, John J. Aird, Emma K. Foley, Niamh Clarke, Narayanasamy Ravi, Dermot O’Toole, John V. Reynolds, Breandán N. Kennedy, Jacintha O’Sullivan. Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinoma. Oncotarget 2018; 9(72) doi: 10.18632/oncotarget.25950
|
| 29 |
Cheng-Che Tu, Po-Kuei Hsu. Current choices and prospects in management of postoperative esophageal cancer patients. Asian Journal of Surgery 2019; 42(1) doi: 10.1016/j.asjsur.2018.06.009
|
| 30 |
Sebastien Gilbert, Gillian K. Gresham, Derek J. Jonker, Andrew J. Seely, Donna E. Maziak, Farid M. Shamji, Jason Pantarotto, Sudhir Sundaresan. Impact of Patient Selection, Disease Progression, and Adverse Events on Esophageal Cancer Outcomes After Trimodality Therapy. The Annals of Thoracic Surgery 2012; 94(5) doi: 10.1016/j.athoracsur.2012.05.044
|
| 31 |
Dong-Bin Wang, Zhong-Yi Sun, Li-Min Deng, De-Qing Zhu, Hong-Gang Xia, Peng-Zhi Zhu. Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma. Chinese Medical Journal 2016; 129(24) doi: 10.4103/0366-6999.195464
|
| 32 |
Cengiz Gemici, Gokhan Yaprak, Hasan Fevzi Batirel, Mahmut Ilhan, Alpaslan Mayadagli. Radiation field size and dose determine oncologic outcome in esophageal cancer. World Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-1024-0
|
| 33 |
Alex G. Little, Antoon E. Lerut, David H. Harpole, Wayne L. Hofstetter, John D. Mitchell, Nasser K. Altorki, Mark J. Krasna. The Society of Thoracic Surgeons Practice Guidelines on the Role of Multimodality Treatment for Cancer of the Esophagus and Gastroesophageal Junction. The Annals of Thoracic Surgery 2014; 98(5) doi: 10.1016/j.athoracsur.2014.07.069
|
| 34 |
Yunpeng Zhao, Yongqiang Wang, Lei Shan, Chuanliang Peng, Wenhao Zhang, Xiaogang Zhao. A network meta-analysis for neoadjuvant and adjuvant treatments for resectable squamous cell carcinoma of esophagus. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-86102-8
|
| 35 |
Keiichi Jingu, Hisanori Ariga, Kenji Nemoto, Kakutaro Narazaki, Rei Umezawa, Ken Takeda, Masashi Koto, Toshiyuki Sugawara, Masaki Kubozono, Go Miyata, Ko Onodera, Shogo Yamada. Long-Term Results of Radiochemotherapy for Solitary Lymph Node Metastasis After Curative Resection of Esophageal Cancer. International Journal of Radiation Oncology*Biology*Physics 2012; 83(1) doi: 10.1016/j.ijrobp.2011.06.1978
|
| 36 |
Fang Li, Tao Li, Li Liu, Jiahua Lv, Yanqiong Song, Churong Li, Peng Diao. Concurrent versus Sequential Chemoradiotherapy for Esophageal Cancer among Chinese Population: A Meta-Analysis. Tumori Journal 2015; 101(4) doi: 10.5301/tj.5000314
|
| 37 |
Karsten Bartels, Matthew Fiegel, Quinn Stevens, Bryan Ahlgren, Nathaen Weitzel. Approaches to Perioperative Care for Esophagectomy. Journal of Cardiothoracic and Vascular Anesthesia 2015; 29(2) doi: 10.1053/j.jvca.2014.10.029
|
| 38 |
Luis F. Tapias, Douglas J. Mathisen, Cameron D. Wright, John C. Wain, Henning A. Gaissert, Ashok Muniappan, Michael Lanuti, Dean M. Donahue, Christopher R. Morse. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy. The Annals of Thoracic Surgery 2016; 101(3) doi: 10.1016/j.athoracsur.2015.09.062
|
| 39 |
Marcus W. Wiedmann, Joachim Mössner. International Manual of Oncology Practice. 2015; doi: 10.1007/978-3-319-21683-6_10
|
| 40 |
Ravi Shridhar, Khaldoun Almhanna, Sarah E. Hoffe, Matthew Biagioli, Domenico Coppola, Kenneth L. Meredith. The American Cancer Society's Oncology in Practice. 2018; doi: 10.1002/9781118592168.ch3
|
| 41 |
Ravi Shridhar, Reza Imani-Shikhabadi, Bonnie Davis, Oscar A. Streeter, Charles R. Thomas. Curative Treatment of Esophageal Cancer; An Evidenced Based Review. Journal of Gastrointestinal Cancer 2013; 44(4) doi: 10.1007/s12029-013-9511-9
|
| 42 |
Kelvin K. W. Chan, Ronak Saluja, Keemo Delos Santos, Kelly Lien, Keya Shah, Gemma Cramarossa, Xiaofu Zhu, Rebecca K.S. Wong. Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta‐analysis. International Journal of Cancer 2018; 143(2) doi: 10.1002/ijc.31312
|
| 43 |
Ravi Shridhar, Khaldoun Almhanna, Kenneth L. Meredith, Matthew C. Biagioli, Michael D. Chuong, Alex Cruz, Sarah E. Hoffe. Radiation Therapy and Esophageal Cancer. Cancer Control 2013; 20(2) doi: 10.1177/107327481302000203
|
| 44 |
Reema Goel, Rathan M. Subramaniam, Jason W. Wachsmann. PET/Computed Tomography Scanning and Precision Medicine. PET Clinics 2017; 12(4) doi: 10.1016/j.cpet.2017.05.001
|
| 45 |
Christine Kestens, Richard van Hillegersberg, Peter Siersema. Ontwikkelingen in de oncologie. 2014; doi: 10.1007/978-90-368-0436-3_24
|
| 46 |
Deirdre J Cohen, Jaffer Ajani. An expert opinion on esophageal cancer therapy. Expert Opinion on Pharmacotherapy 2011; 12(2) doi: 10.1517/14656566.2010.517748
|
| 47 |
|
| 48 |
Basil S. Nasir, Moishe Liberman. Difficult Decisions in Thoracic Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach 2014; 1 doi: 10.1007/978-1-4471-6404-3_23
|
| 49 |
Peter S. N. van Rossum, Richard van Hillegersberg, Frederiek M. Lever, Irene M. Lips, Astrid L. H. M. W. van Lier, Gert J. Meijer, Maarten S. van Leeuwen, Marco van Vulpen, Jelle P. Ruurda. Imaging strategies in the management of oesophageal cancer: what’s the role of MRI?. European Radiology 2013; 23(7) doi: 10.1007/s00330-013-2773-6
|
| 50 |
Pierfrancesco Franco, Alba Fiorentino, Francesco Dionisi, Michele Fiore, Silvia Chiesa, Stefano Vagge, Francesco Cellini, Luciana Caravatta, Mario Tombolini, Fiorenza De Rose, Icro Meattini, Gianluca Mortellaro, Giuseppina Apicella, Lorenza Marino, Daniela Greto. Combined Modality Therapy for Thoracic and head and Neck Cancers: A Review of Updated Literature Based on a Consensus Meeting. Tumori Journal 2016; 102(5) doi: 10.5301/tj.5000525
|
| 51 |
Yan Lin, Shou-Feng Wang, Huan-Wei Liang, Yang Liu, Wei Huang, Xin-Bin Pan. Preoperative radiotherapy in patients with locally advanced esophageal squamous cell carcinoma: a narrative review. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1613954
|
| 52 |
Kaushik Mukherjee, A. Bapsi Chakravarthy, Laura W. Goff, Wael El-Rifai. Esophageal Adenocarcinoma: Treatment Modalities in the Era of Targeted Therapy. Digestive Diseases and Sciences 2010; 55(12) doi: 10.1007/s10620-010-1187-4
|
| 53 |
Xavier Cuenca, Christophe Hennequin, Elif Hindié, Sofia Rivera, Laetitia Vercellino, Valérie Baruch-Hennequin, Jean-Marc Gornet, Pierre Cattan, Mircea Chirica, Laurent Quéro. Evaluation of early response to concomitant chemoradiotherapy by interim 18F-FDG PET/CT imaging in patients with locally advanced oesophageal carcinomas. European Journal of Nuclear Medicine and Molecular Imaging 2013; 40(4) doi: 10.1007/s00259-012-2325-3
|
| 54 |
Kuai-Le Zhao, Guo-Liang Jiang, Xiao-Mao Guo, Yi Xia, Zhen Zhang, Yun Chen, Jun-Hua Zhang, Jia-Ying Deng, Jian-Hong Fan, Harun Badakhshi, Hua-Rong Tang, Da-Shan Ai, Han-Ting Zhu. Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma. World Journal of Gastroenterology 2017; 23(3): 540-546 doi: 10.3748/wjg.v23.i3.540
|
| 55 |
Amy M. Buckley, Becky AS. Bibby, Margaret R. Dunne, Susan A. Kennedy, Maria B. Davern, Breandán N. Kennedy, Stephen G. Maher, Jacintha O’Sullivan. Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells. Pharmaceuticals 2019; 12(1) doi: 10.3390/ph12010033
|
| 56 |
Neil Bryan Newman, A. Bapsi Chakravarthy. Esophageal Cancer. 2020; doi: 10.1007/978-3-030-29832-6_10
|
| 57 |
Felice Pasini, Anna Paola Fraccon, Giovanni de Manzoni. Treatment of Esophageal and Hypopharyngeal Squamous Cell Carcinoma. Updates in Surgery 2012; doi: 10.1007/978-88-470-2330-7_12
|
| 58 |
M. Hingorani, T. Crosby, A. Maraveyas, S. Dixit, A. Bateman, R. Roy. Neoadjuvant Chemoradiotherapy for Resectable Oesophageal and Gastro-oesophageal Junction Cancer—Do We Need Another Randomised Trial?. Clinical Oncology 2011; 23(10) doi: 10.1016/j.clon.2011.05.005
|
| 59 |
R. J. L. F. Loffeld, P. E. P. Dekkers. Experience with Oesophageal Cancer: A Ten-Year Single Centre Study Reflecting Daily Practice. ISRN Gastroenterology 2013; 2013 doi: 10.1155/2013/205417
|
| 60 |
Chin Hur, Joshua R Sonett, Julian A Abrams, Aaron Oh, Elisabeth Silver, Lindsay Danielle Kumble. Treatment of early stage (T1) esophageal adenocarcinoma: Personalizing the best therapy choice. World Journal of Meta-Analysis 2019; 7(9): 406-417 doi: 10.13105/wjma.v7.i9.406
|
| 61 |
Christine Kestens, Richard van Hillegersberg, Peter Siersema. Oesofaguscarcinoom. Huisarts en wetenschap 2014; 57(1) doi: 10.1007/s12445-014-0015-z
|
| 62 |
Luis F. Tapias, Christopher R. Morse. Minimally Invasive Ivor Lewis Esophagectomy after Induction Therapy Yields Similar Early Outcomes to Surgery Alone. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery 2011; 6(5) doi: 10.1177/155698451100600508
|
| 63 |
O. Dupuis, G. Ganem, G. Béra, Y. Pointreau, O. Pradier, P. Martin, X. Mirabel, F. Denis. Cancer de l’œsophage. Cancer/Radiothérapie 2010; 14 doi: 10.1016/S1278-3218(10)70010-X
|
| 64 |
Ryan P. Merkow, Karl Y. Bilimoria, Martin D. McCarter, Warren B. Chow, Clifford Y. Ko, David J. Bentrem. Use of Multimodality Neoadjuvant Therapy for Esophageal Cancer in the United States: Assessment of 987 Hospitals. Annals of Surgical Oncology 2012; 19(2) doi: 10.1245/s10434-011-1945-3
|
| 65 |
Peng Jin, Astrid van der Horst, Rianne de Jong, Jeanin E. van Hooft, Martijn Kamphuis, Niek van Wieringen, Melanie Machiels, Arjan Bel, Maarten C.C.M. Hulshof, Tanja Alderliesten. Marker-based quantification of interfractional tumor position variation and the use of markers for setup verification in radiation therapy for esophageal cancer. Radiotherapy and Oncology 2015; 117(3) doi: 10.1016/j.radonc.2015.10.005
|
| 66 |
Jiaying Deng, Chunyu Wang, Mingqiong Xiang, Fatao Liu, Yun Liu, Kuaile Zhao. Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinoma. Diagnostic Pathology 2014; 9(1) doi: 10.1186/1746-1596-9-151
|
| 67 |
Arnulf H. Hölscher, Ulrich K. Fetzner. Multimodale Therapie mit kurativem Ansatz. Viszeralmedizin 2012; 28(2) doi: 10.1159/000338283
|
| 68 |
Lei Jiang, Ke-hu Yang, Quan-lin Guan, Yan Chen, Peng Zhao, Jin-hui Tian. Survival Benefit of Neoadjuvant Chemotherapy for Resectable Cancer of the Gastric and Gastroesophageal Junction. Journal of Clinical Gastroenterology 2015; 49(5) doi: 10.1097/MCG.0000000000000212
|
| 69 |
Dong-Bin Wang, Xun Zhang, Hong-Li Han, Yi-Jun Xu, Da-Qiang Sun, Zhen-Liang Shi. Neoadjuvant Chemoradiotherapy Could Improve Survival Outcomes for Esophageal Carcinoma: A Meta-Analysis. Digestive Diseases and Sciences 2012; 57(12) doi: 10.1007/s10620-012-2263-8
|
| 70 |
Aminah Jatoi, Gamini Soori, Nathan R. Foster, Bradley K. Hiatt, James A. Knost, Tom R. Fitch, Matthew D. Callister, Francis C. Nichols, Tim M. Husted, Steven R. Alberts. Phase II Study of Preoperative Pemetrexed, Carboplatin, and Radiation Followed by Surgery for Locally Advanced Esophageal Cancer and Gastroesophageal Junction Tumors. Journal of Thoracic Oncology 2010; 5(12) doi: 10.1097/JTO.0b013e3181fb5c3e
|
| 71 |
Yaping Xu, Xinmin Yu, Qixun Chen, Weimin Mao. Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?. World Journal of Surgical Oncology 2012; 10(1) doi: 10.1186/1477-7819-10-173
|
| 72 |
H X Yang, W Feng, J C Wei, T S Zeng, Z D Li, L J Zhang, P Lin, R Z Luo, J H He, J H Fu. Support vector machine-based nomogram predicts postoperative distant metastasis for patients with oesophageal squamous cell carcinoma. British Journal of Cancer 2013; 109(5) doi: 10.1038/bjc.2013.379
|
| 73 |
J. Stiekema, H. Boot, B.M.P. Aleman, L.F.A. Wessels, J.W. van Sandick. Prognostication and prediction using gene expression profiling in oesophageal cancer. European Journal of Surgical Oncology (EJSO) 2013; 39(1) doi: 10.1016/j.ejso.2012.07.008
|
| 74 |
Leila Sisic, Susanne Blank, Wilko Weichert, Dirk Jäger, Christoph Springfeld, Marcel Hochreiter, Markus Büchler, Katja Ott. Prognostic impact of lymph node involvement and the extent of lymphadenectomy (LAD) in adenocarcinoma of the esophagogastric junction (AEG). Langenbeck's Archives of Surgery 2013; 398(7) doi: 10.1007/s00423-013-1101-6
|
| 75 |
Nathan W. Bronson, Renato A. Luna, John G. Hunter. Tailoring Esophageal Cancer Surgery. Seminars in Thoracic and Cardiovascular Surgery 2012; 24(4) doi: 10.1053/j.semtcvs.2012.11.001
|
| 76 |
|
| 77 |
Magali Cabau, Guillaume Luc, Eric Terrebonne, Geneviève Belleanne, Véronique Vendrely, Antonio Sa Cunha, Denis Collet. Lymph node invasion might have more prognostic impact than R status in advanced esophageal adenocarcinoma. The American Journal of Surgery 2013; 205(6) doi: 10.1016/j.amjsurg.2012.08.009
|
| 78 |
Peter D. Siersema, Frank P. Vleggaar. Esophageal strictures, tumors, and fistulae: alternative techniques for palliating primary esophageal cancer. Techniques in Gastrointestinal Endoscopy 2010; 12(4) doi: 10.1016/j.tgie.2011.02.015
|
| 79 |
Ranjit Joseph, Shachar Laks, Michael Meyers, Autumn J. McRee. Multidisciplinary Approach to the Management of Esophageal Malignancies. World Journal of Surgery 2017; 41(7) doi: 10.1007/s00268-017-4009-4
|